TDRKH-AS1
gene geneOn this page
Also known as RP11-98D18.9
Summary
TDRKH-AS1 (TDRKH antisense RNA 1, HGNC:40578) is a long non-coding RNA gene on chromosome 1q21.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:40578 |
| Approved symbol | TDRKH-AS1 |
| Name | TDRKH antisense RNA 1 |
| Location | 1q21.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | RP11-98D18.9 |
| Ensembl gene | ENSG00000203288 |
| Ensembl biotype | lncRNA |
| Entrez | 109729141 |
| RNAcentral | URS0000BC4629 — lncRNA, 1099 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 10 lncRNA
ENST00000389897, ENST00000533481, ENST00000660232, ENST00000703074, ENST00000729139, ENST00000729140, ENST00000729141, ENST00000729142, ENST00000729143, ENST00000729144
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000389897 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001679001 | 151793815 | 151794402 |
| ENSE00001728290 | 151790842 | 151791245 |
Expression profiles
Bgee: expression breadth ubiquitous, 165 present calls, max score 88.87.
FANTOM5 (CAGE): breadth broad, TPM avg 2.2447 / max 29.1327, expressed in 756 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 5248 | 1.2994 | 520 |
| 5249 | 0.9453 | 389 |
Top tissues by expression
235 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 88.87 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.46 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.69 | gold quality |
| left testis | UBERON:0004533 | 76.89 | gold quality |
| right testis | UBERON:0004534 | 76.44 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 76.43 | gold quality |
| cerebellar cortex | UBERON:0002129 | 76.30 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 76.21 | gold quality |
| testis | UBERON:0000473 | 74.85 | gold quality |
| cerebellum | UBERON:0002037 | 74.71 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 72.88 | gold quality |
| medial globus pallidus | UBERON:0002477 | 72.80 | gold quality |
| cortical plate | UBERON:0005343 | 70.85 | gold quality |
| spinal cord | UBERON:0002240 | 70.13 | gold quality |
| bone marrow cell | CL:0002092 | 69.33 | silver quality |
| ganglionic eminence | UBERON:0004023 | 68.63 | gold quality |
| sperm | CL:0000019 | 68.55 | gold quality |
| ventricular zone | UBERON:0003053 | 68.47 | gold quality |
| prefrontal cortex | UBERON:0000451 | 68.37 | gold quality |
| oviduct epithelium | UBERON:0004804 | 68.03 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 67.25 | gold quality |
| globus pallidus | UBERON:0001875 | 67.05 | gold quality |
| calcaneal tendon | UBERON:0003701 | 67.03 | gold quality |
| muscle of leg | UBERON:0001383 | 66.83 | gold quality |
| granulocyte | CL:0000094 | 66.82 | gold quality |
| gastrocnemius | UBERON:0001388 | 66.73 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 66.42 | gold quality |
| hypothalamus | UBERON:0001898 | 65.68 | gold quality |
| right frontal lobe | UBERON:0002810 | 65.51 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 65.37 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.04 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis. (PMID:38008726)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.